ebook Munafa Stock Market Course + Intraday & FNO calls  

       

500257 announcements Lupin Ltd. announcements and dividends declared BSE

Lupin Ltd. Complete list of announcements declared & dividend announcements by Lupin Ltd. 500257

Lupin Ltd. 500257 listed on BSE and deals in

Announcements and dividends declared by Lupin Ltd. 500257

Lupin receives USFDA approval for Modafinil Tablets USP
The U.S. FDA has approved Lupin's Modafinil Tablets USP, 100 mg and 200 mg as bioequivalent to the reference listed drug (RLD), Provigil Tablets of Nuvo Pharmaceuticals (Ireland) DAC, and is indicated to improve wakefulness in adult patients with excessiv
Announcement as on 04 September 2026

Lupin gets USFDA approval for Modafinil tablets to treat excessive sleepiness
Pharmaceutical major Lupin announced its USFDA approval for Modafinil tablets. These tablets are used to treat excessive sleepiness in adult patients. The approved drug is bioequivalent to Provigil Tablets of Nuvo Pharmaceuticals. Modafinil tablets had
Announcement as on 04 September 2026

Lupin share falls 2%; Citi downgrades to Sell, cuts target price to Rs 2,050
Lupin shares fell after Citi downgraded the stock to ‘Sell’ and cut its target price to Rs 2,050. The brokerage expects weaker US base-business sales, margin pressure and limited benefits from new products. Citi also reduced FY27 EPS estimates by 14%. Lupi
Announcement as on 27 August 2026

Lupin allots 30,967 equity shares under ESOP
In view of the above, the issued and paid-up share capital of the Company has increased to Rs 91,45,31,722 consisting of 45,72,65,861 equity shares of Rs 2/- each.
Announcement as on 25 August 2026

Lupin arm to commercialise YUVEZZI eye drop across key European markets
Lupin's VISUfarma BV has secured exclusive rights for YUVEZZI in key European markets. This ophthalmic product treats loss of clear close-up vision in adults. VISUfarma will undertake regulatory activities and commercialization of the eye drop. The agreeme
Announcement as on 20 August 2026

Announcements by Lupin Ltd. first page | Next page |

500257 Lupin Ltd. current price & indicator signals

Moving Averages for Lupin Ltd.

  • 5Day Average: 2145.32
  • 12Day Average: 2168.21
  • 20Day Average: 2201.82
  • 50Day Average: 2339.32
  • 100Day Average: 2319.74
  • 150Day Average: 2300.54
  • 200Day Average: 2251.84

500257 Indicators & signals

Indicator MACD (12,26,9)

2172.19, 2229.76, -54.46
Indicator MACD is in negative zone

Indicator ADX (14)

29.74, 13.86, 25.58
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 46
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 500257 Lupin Ltd. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
04 Fri Sep 2026 2111.00 2104.40 to 2149.75 -1.12% 0.26 times
03 Thu Sep 2026 2135.00 2135.00 to 2170.00 -0.82% 1.84 times
02 Wed Sep 2026 2152.60 2136.10 to 2192.95 0.12% 3.19 times
01 Tue Sep 2026 2150.00 2140.00 to 2198.30 -1.29% 0.21 times
31 Mon Aug 2026 2178.00 2145.55 to 2209.00 0.14% 0.34 times
28 Fri Aug 2026 2175.00 2153.50 to 2179.50 0.48% 0.21 times
27 Thu Aug 2026 2164.60 2145.35 to 2187.45 -1.21% 0.66 times
26 Wed Aug 2026 2191.20 2175.00 to 2237.00 0.74% 0.41 times
25 Tue Aug 2026 2175.00 2159.40 to 2185.00 -0.68% 2.56 times
24 Mon Aug 2026 2190.00 2181.00 to 2224.50 -0.14% 0.16 times
21 Fri Aug 2026 2193.00 2186.85 to 2215.00 -0.46% 0.42 times
20 Thu Aug 2026 2203.10 2203.10 to 2243.05 -0.76% 0.1 times

Videos related to: 500257 announcements Lupin Ltd. announcements and dividends declared BSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

500257 announcements Lupin Ltd. announcements and dividends declared BSE

 

Back to top